| |
| Development History of Company |
| 2009 | Phase 1 project of the Qinhuangdao API production base was completed and put into production. |
| 2007 | China Reproductive Health Industry Association sponsored by the National Population and Family Planning Commission was established; Zizhu joined the Association and was the only enterprise at vice-president level; the trademarks of “Yuting”&“Zizhu” were recognized as China’s well-known trademark. |
| 2005 | It was listed in the China’s Top 100 profitable pharmaceutical enterprises; won the Advanced Award of Beijing’s Quality Management awarded by Beijing government. |
| 2004 | It carried out technical cooperation with the American Womens Reproductive Health Company. |
| 2003 | Set up Beijing Molec Technology Development Company with four leading experts in the grand “863” and “973” project of the toxicological institute of China Military Medicine Academy. |
| 2003 | Set up Beijing Ziruite Science and Technology Co., Ltd. with US RHT Company |
| 2001 | It developed Misoprostol Tablets that was the Mifepristone Tablets’ co-administered drug, and Mifepristone Tablets 10mg (Simi’an). The former ended the reliance on the imported Misoprostol Tablets. |
| Dec. 28 2000 | Name changed as Beijing Zizhu Pharmaceutical Co., Ltd. |
| Jun.1996 | Beijing 3rd Pharmaceutical Factory established Hanmi Pharmaceutical Co. Ltd. jointly with Korea Hanmi Pharmaceutical Co. Ltd. and Beijing Tianzhu Airport Industry Development Company. |
| Dec. 27 1995 | Beijing 3rd Pharmaceutical Factory moved to the new factory. |
| Mar. 1991 | Lay the foundation of new site of Beijing 3rd Pharmaceutical Factory |
| Jul. 29 1989 | Completion and opening of Beijing Zizhu Mansion of Beijing 3rd Pharmaceutical Factory. |
| Jan. 1987 | Establishment of Beijing Sino-Swiss Ciba Pharmaceutical Co., Ltd. (now as Beijing Novartis Pharma Ltd.) with Swiss Ciba Pharmaceutical Co., Ltd. |
| Aug. 21, 1969 | Foundation of Beijing 3rd Pharmaceutical Factory |
|
|
|
